USO - Oncology Hematology Care

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Acute myeloid leukaemia1 trial
• Colorectal cancer1 trial
• Lung cancer1 trial
• Multiple myeloma1 trial
• Myelodysplastic syndromes1 trial
• Prostate cancer1 trial

Phase

• Phase 1/21 trial
• Phase 31 trial

Status

• Completed1 trial
• Recruiting1 trial

Lead sponsor

• Eli Lilly and Company1 trial
• Karyopharm Therapeutics Inc1 trial

Running trials

• Recruiting

  A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  NCT06119581· Phase 3· Eli Lilly and Company· Source

  Contact: Patrick Ward (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer1 recruiting

Closed trials

• Completed

  Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications

  NCT02649790· Phase 1/2· Karyopharm Therapeutics Inc· Source